TUBE1

gene
On this page

Also known as dJ142L7.2FLJ22589TUBE

Summary

TUBE1 (tubulin epsilon 1, HGNC:20775) is a protein-coding gene on chromosome 6q21, encoding Tubulin epsilon chain (Q9UJT0). It is a selective cancer dependency (DepMap: 56.5% of cell lines).

This gene encodes a member of the tubulin superfamily. This protein localizes to the centriolar sub-distal appendages that are associated with the older of the two centrioles after centrosome duplication. This protein plays a central role in organization of the microtubules during centriole duplication. A pseudogene of this gene is found on chromosome 5.

Source: NCBI Gene 51175 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 66 total — 1 pathogenic
  • Cancer dependency (DepMap): dependent in 56.5% of screened cell lines
  • MANE Select transcript: NM_016262

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20775
Approved symbolTUBE1
Nametubulin epsilon 1
Location6q21
Locus typegene with protein product
StatusApproved
AliasesdJ142L7.2, FLJ22589, TUBE
Ensembl geneENSG00000074935
Ensembl biotypeprotein_coding
OMIM607345
Entrez51175

Gene structure

Transcript identifiers

Ensembl transcripts: 15 — 5 retained_intron, 5 protein_coding, 3 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined

ENST00000368657, ENST00000368662, ENST00000441191, ENST00000603621, ENST00000603651, ENST00000603722, ENST00000604689, ENST00000604743, ENST00000604814, ENST00000604967, ENST00000605457, ENST00000856770, ENST00000856771, ENST00000937354, ENST00000956039

RefSeq mRNA: 1 — MANE Select: NM_016262 NM_016262

CCDS: CCDS5100

Canonical transcript exons

ENST00000368662 — 12 exons

ExonStartEnd
ENSE00001447692112087410112087482
ENSE00001956692112070663112071570
ENSE00003523823112072758112072898
ENSE00003537359112084189112084246
ENSE00003549928112086556112086608
ENSE00003562346112075937112076112
ENSE00003606979112074710112074850
ENSE00003646398112071902112072076
ENSE00003657301112079633112079754
ENSE00003679572112076322112076509
ENSE00003679984112087233112087306
ENSE00003683668112081092112081207

Expression profiles

Bgee: expression breadth ubiquitous, 254 present calls, max score 95.50.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.8164 / max 206.8422, expressed in 1796 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
7515020.42041794
751510.3960176

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right hemisphere of cerebellumUBERON:001489095.50gold quality
cerebellar hemisphereUBERON:000224595.35gold quality
cerebellar cortexUBERON:000212995.28gold quality
oocyteCL:000002395.06gold quality
cerebellumUBERON:000203794.58gold quality
secondary oocyteCL:000065593.84gold quality
epithelial cell of pancreasCL:000008393.78gold quality
calcaneal tendonUBERON:000370193.52gold quality
body of uterusUBERON:000985393.32gold quality
right lobe of liverUBERON:000111492.75gold quality
cardiac muscle of right atriumUBERON:000337991.96gold quality
right atrium auricular regionUBERON:000663191.70gold quality
cardiac atriumUBERON:000208191.58gold quality
C1 segment of cervical spinal cordUBERON:000646991.55gold quality
right ovaryUBERON:000211891.53gold quality
left ovaryUBERON:000211991.51gold quality
apex of heartUBERON:000209891.44gold quality
liverUBERON:000210791.27gold quality
endocervixUBERON:000045890.89gold quality
heart left ventricleUBERON:000208490.78gold quality
spinal cordUBERON:000224090.66gold quality
body of pancreasUBERON:000115090.58gold quality
adrenal tissueUBERON:001830390.56gold quality
cardiac ventricleUBERON:000208290.52gold quality
heartUBERON:000094890.41gold quality
left ventricle myocardiumUBERON:000656690.27gold quality
right uterine tubeUBERON:000130290.16gold quality
tibial nerveUBERON:000132390.13gold quality
adenohypophysisUBERON:000219690.02gold quality
ovaryUBERON:000099289.91gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.40
E-GEOD-111727no240.62
E-GEOD-75367no184.22

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

49 targeting TUBE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-340-5P100.0072.504437
HSA-MIR-3163100.0077.238605
HSA-MIR-5692A100.0074.406850
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-186-5P99.9970.833707
HSA-MIR-1213699.9872.815713
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-590-3P99.9674.346478
HSA-MIR-545-3P99.9570.742783
HSA-LET-7C-3P99.9573.422862
HSA-MIR-589-3P99.9169.622088
HSA-MIR-548AR-3P99.8571.263889
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-548AZ-3P99.8270.563549
HSA-MIR-548BC99.8270.613524
HSA-MIR-548E-3P99.8270.593514
HSA-MIR-548F-3P99.8270.593540
HSA-MIR-374C-5P99.8072.062910
HSA-MIR-655-3P99.8072.192909
HSA-MIR-451799.7669.191867
HSA-MIR-548A-3P99.7670.583524
HSA-MIR-3680-3P99.7572.513095
HSA-MIR-148A-3P99.7473.771700
HSA-MIR-148B-3P99.7473.751700
HSA-MIR-152-3P99.7473.751703
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-518A-5P99.7069.012209

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 56.5% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • EB1 recognizes the nucleotide state of tubulin in the microtubule lattice (PMID:19851462)
  • Here, the authors report that centrioles in delta-tubulin and epsilon-tubulin null mutant human cells lack triplet microtubules and fail to undergo centriole maturation. (PMID:28906251)
  • Exome sequencing of child-parent trios with bladder exstrophy: Findings in 26 children. (PMID:34355505)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriotube1ENSDARG00000096620
mus_musculusTube1ENSMUSG00000019845
rattus_norvegicusTube1ENSRNOG00000000598

Paralogs (23): TUBG2 (ENSG00000037042), TUBA3D (ENSG00000075886), TUBB1 (ENSG00000101162), TUBB4A (ENSG00000104833), TUBD1 (ENSG00000108423), TUBA1B (ENSG00000123416), TUBA4A (ENSG00000127824), TUBG1 (ENSG00000131462), TUBB2A (ENSG00000137267), TUBB2B (ENSG00000137285), TUBA3E (ENSG00000152086), TUBA1A (ENSG00000167552), TUBA1C (ENSG00000167553), TUBB8B (ENSG00000173213), TUBB6 (ENSG00000176014), TUBAL3 (ENSG00000178462), TUBA8 (ENSG00000183785), TUBB4B (ENSG00000188229), TUBB (ENSG00000196230), TUBA3C (ENSG00000198033), TUBA4B (ENSG00000243910), TUBB3 (ENSG00000258947), TUBB8 (ENSG00000261456)

Protein

Protein identifiers

Tubulin epsilon chainQ9UJT0 (reviewed: Q9UJT0)

Alternative names: Epsilon-tubulin

All UniProt accessions (4): Q9UJT0, A0A0B4J2B9, S4R3K3, S4R424

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Found in a complex with TEDC1, TEDC2, TUBE1 and TUBD1.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome.

Similarity. Belongs to the tubulin family.

RefSeq proteins (1): NP_057346* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000217TubulinFamily
IPR003008Tubulin_FtsZ_GTPaseDomain
IPR004057Epsilon_tubulinFamily
IPR008280Tub_FtsZ_CHomologous_superfamily
IPR017975Tubulin_CSConserved_site
IPR018316Tubulin/FtsZ_2-layer-sand-domDomain
IPR023123Tubulin_CHomologous_superfamily
IPR036525Tubulin/FtsZ_GTPase_sfHomologous_superfamily

Pfam: PF00091, PF03953

UniProt features (4 total): sequence conflict 2, chain 1, binding site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UJT0-F189.070.73

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (1): 148–154

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 130 (showing top): GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GSE45365_NK_CELL_VS_CD11B_DC_UP, MODULE_453, GOCC_MICROTUBULE_ORGANIZING_CENTER, KOYAMA_SEMA3B_TARGETS_UP, GOCC_CENTROSOME, GOBP_MITOTIC_CELL_CYCLE, PEART_HDAC_PROLIFERATION_CLUSTER_DN, RFX1_02, ZHENG_BOUND_BY_FOXP3, MARSON_BOUND_BY_E2F4_UNSTIMULATED, ZHENG_FOXP3_TARGETS_IN_THYMUS_DN, GARY_CD5_TARGETS_UP, GOCC_PERICENTRIOLAR_MATERIAL

GO Biological Process (4): microtubule cytoskeleton organization (GO:0000226), mitotic cell cycle (GO:0000278), centrosome cycle (GO:0007098), microtubule-based process (GO:0007017)

GO Molecular Function (3): structural constituent of cytoskeleton (GO:0005200), GTP binding (GO:0005525), nucleotide binding (GO:0000166)

GO Cellular Component (6): pericentriolar material (GO:0000242), cytoplasm (GO:0005737), microtubule (GO:0005874), centrosome (GO:0005813), cytoskeleton (GO:0005856), microtubule cytoskeleton (GO:0015630)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cytoskeleton organization2
cytoskeleton2
cellular anatomical structure2
microtubule-based process1
cell cycle1
mitotic nuclear division1
cell cycle process1
microtubule organizing center organization1
cellular process1
structural molecule activity1
guanyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
nucleoside phosphate binding1
heterocyclic compound binding1
centrosome1
intracellular anatomical structure1
microtubule cytoskeleton1
polymeric cytoskeletal fiber1
centriole1
microtubule organizing center1
intracellular membraneless organelle1

Protein interactions and networks

STRING

3231 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TUBE1CNTRLQ7Z7A1819
TUBE1NINQ8N4C6788
TUBE1CEP170Q5SW79738
TUBE1ODF2Q5BJF6732
TUBE1SASS6Q6UVJ0701
TUBE1CC2D2AQ9P2K1577
TUBE1PLK4O00444576
TUBE1TUBD1Q9UJT1576
TUBE1CEP128Q6ZU80564
TUBE1NINLQ9Y2I6526
TUBE1CEP192Q8TEP8526
TUBE1CPAPQ9HC77507
TUBE1CEP135Q66GS9501
TUBE1STILQ15468494
TUBE1POC5Q8NA72489

IntAct

10 interactions, top by confidence:

ABTypeScore
TUBE1TEDC2psi-mi:“MI:0914”(association)0.530
FGL1DNM1Lpsi-mi:“MI:0914”(association)0.350
DEF8DPYSL4psi-mi:“MI:0914”(association)0.350
NPM1RPS3Apsi-mi:“MI:0914”(association)0.350
P2RY10POTEFpsi-mi:“MI:0914”(association)0.350
GPR182METTL15psi-mi:“MI:0914”(association)0.350
GPR45VWA8psi-mi:“MI:0914”(association)0.350

BioGRID (32): TUBE1 (Affinity Capture-MS), TUBD1 (Affinity Capture-MS), C16orf59 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), C14orf80 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBD1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), C16orf59 (Affinity Capture-MS), C14orf80 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS), TUBE1 (Affinity Capture-MS)

ESM2 similar proteins: A1A4J7, A2CEI4, A2RV06, B2RYI0, E7F654, E7FAW3, E9QAM5, F1Q7Z7, F1QNV4, O01939, O75064, O75153, O95248, P97564, Q08CY4, Q0P4Q0, Q0VA04, Q1L908, Q1LXZ7, Q2YDW2, Q32PH0, Q3T1I9, Q3U1Y4, Q4JF28, Q5U249, Q61586, Q6GPP1, Q6PD24, Q6TEN6, Q6ZNJ1, Q6ZPE2, Q6ZPG2, Q6ZQA0, Q6ZTN6, Q764M6, Q7T006, Q7TMQ7, Q7ZVS8, Q80U56, Q861Y6

Diamond homologs: P04688, P18695, P23257, P23258, P23330, P25295, P32348, P34785, P34786, P34787, P38557, P38558, P42271, P49741, P53377, P54403, P54404, P54405, P83887, P83888, P86221, P90548, Q0VCD2, Q32KM1, Q39582, Q41807, Q41808, Q41874, Q4R7T7, Q55AR3, Q6DIM3, Q75A43, Q7Z9Z2, Q8HZV4, Q8SRD2, Q8VCK3, Q9GKK5, Q9NRH3, Q9R1K7, Q9UJT0

SIGNOR signaling

3 interactions.

AEffectBMechanism
“vincaleukoblastine sulfate”“down-regulates activity”TUBE1“chemical inhibition”
TUBE1up-regulatesMicrotubule_polimerization
KATNAL2“down-regulates quantity by destabilization”TUBE1binding

Disease & clinical

Clinical variants and AI predictions

ClinVar

66 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance47
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
155160GRCh38/hg38 6q16.3-22.31(chr6:100054889-120488154)x1Pathogenic

SpliceAI

1749 predictions. Top by Δscore:

VariantEffectΔscore
6:112071900:A:ACdonor_gain1.0000
6:112071900:A:ATdonor_loss1.0000
6:112071900:AC:Adonor_gain1.0000
6:112071901:C:CCdonor_gain1.0000
6:112071901:CC:Cdonor_gain1.0000
6:112071901:CCT:Cdonor_gain1.0000
6:112072047:C:CTacceptor_gain1.0000
6:112072047:C:Tacceptor_gain1.0000
6:112072072:TTAAT:Tacceptor_gain1.0000
6:112072073:TAAT:Tacceptor_gain1.0000
6:112072075:AT:Aacceptor_gain1.0000
6:112072076:TC:Tacceptor_loss1.0000
6:112072077:C:Aacceptor_loss1.0000
6:112072077:C:CCacceptor_gain1.0000
6:112072078:T:Gacceptor_loss1.0000
6:112072796:T:Adonor_gain1.0000
6:112072894:CCAAT:Cacceptor_gain1.0000
6:112072895:CAAT:Cacceptor_gain1.0000
6:112072895:CAATC:Cacceptor_gain1.0000
6:112072897:ATCT:Aacceptor_loss1.0000
6:112072898:TCTG:Tacceptor_loss1.0000
6:112072899:C:CCacceptor_gain1.0000
6:112072899:CT:Cacceptor_loss1.0000
6:112074851:C:CCacceptor_gain1.0000
6:112075932:ATTAC:Adonor_loss1.0000
6:112075933:TTAC:Tdonor_loss1.0000
6:112075934:TA:Tdonor_loss1.0000
6:112075935:ACCTC:Adonor_loss1.0000
6:112075936:C:Tdonor_loss1.0000
6:112076320:A:ACdonor_gain1.0000

AlphaMissense

3147 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:112087271:A:GW21R0.999
6:112087271:A:TW21R0.999
6:112076497:C:TG154E0.998
6:112081093:A:GW109R0.998
6:112081093:A:TW109R0.998
6:112072033:A:GW380R0.997
6:112072033:A:TW380R0.997
6:112074850:G:CS271R0.997
6:112074850:G:TS271R0.997
6:112075938:T:GS271R0.997
6:112081188:T:AE77V0.997
6:112081207:C:GA71P0.997
6:112087269:C:AW21C0.997
6:112087269:C:GW21C0.997
6:112087303:C:AG10V0.997
6:112087303:C:TG10D0.997
6:112072797:C:AG352V0.996
6:112072800:C:AR351I0.996
6:112074757:G:CS302R0.996
6:112074757:G:TS302R0.996
6:112074759:T:GS302R0.996
6:112074834:C:GG277R0.996
6:112074834:C:TG277R0.996
6:112074841:T:AR274S0.996
6:112074841:T:GR274S0.996
6:112074842:C:GR274T0.996
6:112076385:A:CN191K0.996
6:112076385:A:TN191K0.996
6:112076503:C:TG152E0.996
6:112079746:C:TG112D0.996

dbSNP variants (sampled 300 via entrez): RS1000085628 (6:112089430 T>G), RS1000431472 (6:112082923 G>A), RS1000802493 (6:112075710 T>C), RS1000919012 (6:112083320 A>C,T), RS1000968420 (6:112075214 G>A), RS1001653673 (6:112078549 T>C,G), RS1001874389 (6:112077213 C>T), RS1001883373 (6:112084457 A>G), RS1001936459 (6:112078887 C>T), RS1002140771 (6:112070181 C>G,T), RS1002334645 (6:112084137 T>C,G), RS1002390813 (6:112076850 G>A,T), RS1002540482 (6:112080536 T>C), RS1002808664 (6:112073321 T>A), RS1003119907 (6:112086937 T>C,G)

Disease associations

OMIM: gene MIM:607345 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

45 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporineincreases expression4
Aflatoxin B1affects expression, decreases expression, decreases methylation3
sodium arsenitedecreases expression, increases expression2
Air Pollutantsincreases abundance, increases expression, decreases expression2
Benzo(a)pyrenedecreases expression2
Hydrogen Peroxideaffects expression, decreases expression2
Tetrachlorodibenzodioxindecreases expression2
Particulate Matterincreases abundance, increases expression, decreases expression2
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
pirinixic acidaffects binding, increases activity, increases expression1
bisphenol Aaffects expression1
methylparabenincreases expression1
S-(1,2-dichlorovinyl)cysteineincreases expression1
perfluorooctane sulfonic acidincreases expression1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic acidincreases expression1
K 7174increases expression1
ICG 001increases expression1
2,2’,4,4’-tetrabromodiphenyl etherincreases expression1
jinfukangdecreases expression1
prothioconazoleincreases expression1
NSC668394increases expression1
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acidincreases expression1
Sunitinibincreases expression1
Acetaminophenincreases expression1
Gemcitabineincreases expression1
Ampicillindecreases expression1
Dimethyl Sulfoxideincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.